Rna

Edit

Global RNA Therapeutics Market is Expected to Surpass USD 50 Billion Mark by 2034 | DelveInsight

Nasdaq Globe Newswire 09 Oct 2026

The RNA therapeutics market is experiencing significant growth, driven by increasing investments in RNA-based drug development and advances in delivery technologies ... potential of RNA therapies.

Edit

W. M. Keck Foundation Awards $1.3 Million to Map the Hidden 3D Architecture of Human RNA (UCSD - University of California - San Diego)

Public Technologies 07 Oct 2026

Keck Foundation has awarded $1.3 million to the University of California San Diego to support an ambitious research project to map the complex three-dimensional structures formed by RNA molecules in human cells.

Edit

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (Pacific Biosciences of California Inc)

Public Technologies 06 Oct 2026

). The text version of this document is not available ... Attachments Original document Permalink.

Edit

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

Nasdaq Globe Newswire 06 Oct 2026

PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models. PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models ... .

Edit

Character World Brands, a Division of Bioworld, Acquires Björna and CTI to Accelerate European Expansion

Business Wire 06 Oct 2026

The transactions build on the momentum of Character World Brands, which has delivered ye .

Edit

RNA Extraction and Purification Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach ...

Nasdaq Globe Newswire 05 Oct 2026

.

Edit

Florida's Burmese pythons are carrying three previously unknown RNA viruses; scientists are investigating whether they could reach native snakes

The Times of India 05 Oct 2026

Burmese pythons in Florida's Everglades are carrying three previously unknown RNA viruses, raising questions about whether viruses harboured by the invasive snakes could eventually affect native wildlife.

Edit

Nature Medicine Study Shows Resero Bio's Cell-Free RNA Platform Detects Bladder Cancer and Predicts Treatment Response

PR Newswire 05 Oct 2026

New research shows that a non-invasive urine sample can reveal not just whether a tumor is present, but how it will respond to treatment, expanding what cell-free RNA diagnostics can do beyond detection alone.

Edit

Nanoneedle arrays map RNA in fresh tissue without sequencing or amplification

Phys Dot Org 04 Oct 2026

Moreover, its ability to profile messenger RNAs (mRNAs), microRNAs (miRNAs) and RNA methylation provides a potential pathway toward spatial multi-omics that are less dependent on large-scale sequencing infrastructure.

Edit

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

PR Newswire 03 Oct 2026

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease.

Edit

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

PR Newswire 02 Oct 2026

Agreement also gives Novartis exclusive options to license other potential programs leveraging Abogen's RNA proprietary platform ... agreement with Novartis to advance RNA-encoded therapeutics.

Edit

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs (Suzhou Abogen Biosciences Co Ltd)

Public Technologies 02 Oct 2026

) Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs ... potential programs leveraging Abogen's RNA proprietary platform.

Edit

2025 DNA and RNA Synthesis Research Review: Global Market Trends and Forecasts to 2030 | ...

Nasdaq Globe Newswire 01 Oct 2026

Genomics, personalized medicine, CRISPR and gene therapy drive ...

Edit

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA

Hastings Tribune 01 Oct 2026

Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers ... .

Edit

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Nasdaq Globe Newswire 01 Oct 2026

Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers ... .

Podcasts:

Latest News for: rna

Global RNA Therapeutics Market is Expected to Surpass USD 50 Billion Mark by 2034 | DelveInsight

W. M. Keck Foundation Awards $1.3 Million to Map the Hidden 3D Architecture of Human RNA (UCSD - University of California - San Diego)

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (Pacific Biosciences of California Inc)

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

Character World Brands, a Division of Bioworld, Acquires Björna and CTI to Accelerate European Expansion

RNA Extraction and Purification Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach ...

Florida's Burmese pythons are carrying three previously unknown RNA viruses; scientists are investigating whether they could reach native snakes

Nature Medicine Study Shows Resero Bio's Cell-Free RNA Platform Detects Bladder Cancer and Predicts Treatment Response

Nanoneedle arrays map RNA in fresh tissue without sequencing or amplification

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs (Suzhou Abogen Biosciences Co Ltd)

2025 DNA and RNA Synthesis Research Review: Global Market Trends and Forecasts to 2030 | ...

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Article Search

EXPLORE WN.com